PHARMACOTROPHIC OPHTHALMIC COMPOSITION FOR THE TREATMENT OF AMPHIBLYSTEROID PATHOLOGIES HAVING A NEOVASCULAR COMPONENT
CY1125904T1Undetermined Publication Date: 2026-04-17LABORATOIRES THEA SAS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100150T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-12-20
- Filing Date
- 2023-03-17
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2043-03-17
Abstract
The present invention relates to a pharmacotrophic ophthalmic composition comprising resveratrol, advantageously in an amount greater than 20 mg, for administration to a subject receiving anti-VEGF therapy.
Need to check novelty before this filing date? Find Prior Art